Abstract
Prion disease is a unique category of illness, affecting both animals and humans, in which the underlying pathogenesis is related to a conformational change of a normal, self-protein called PrPC (C for cellular) to a pathological and infectious conformer known as PrPSc (Sc for scrapie) (Prusiner, Annu Rev Genet 47:601–623, 2013; Aguzzi and Falsig, Nat Neurosci 15:936–939, 2012; Kretzschmar and Tatzelt, Brain Pathol 23:321–332, 2013; Greenlee and Greenlee, ILAR J 56:7–25, 2015). Currently all prion diseases are without effective treatment and are universally fatal (Prusiner, Annu Rev Genet 47:601–623, 2013; Aguzzi and Falsig, Nat Neurosci 15:936–939, 2012; Greenlee and Greenlee, ILAR J 56:7–25, 2015; Colby and Prusiner, Cold Spring Harb Perspect Biol 3:a006833, 2011; Wisniewski and Goni, Expert Rev Anti Infect Ther 10:307–317, 2012; Sim, Infect Disord Drug Targets 12:144–160, 2012; Rubenstein et al., Prion diagnosis. Manual of clinical and laboratory immunology, 2015). It is increasingly being recognized that many neurodegenerative diseases, such as Alzheimer’s disease (AD), have similarities in their pathogenesis and are “prion-like” (Goedert, Science 349:1255555, 2015; Jucker and Walker, Ann Neurol 70:532–540, 2011; Aguzzi and O’Connor, Nat Rev Drug Discov 9:237–248, 2010; Marciniuk et al., Clin Dev Immunol 2013:473706, 2013). Hence, any effective therapeutic intervention for prion disease would have significant implications for many other common neurodegenerative diseases. Interest in prion disease greatly increased during the emergence of bovine spongiform encephalopathy (BSE) and the resulting appearance of variant CJD (vCJD) in human populations. BSE arose from the feeding of cattle with prion-contaminated meat and bone meal products, while vCJD developed following the entry of BSE into the human food chain (Greenlee and Greenlee, ILAR J 56:7–25, 2015; Harman and Silva, J Am Vet Med Assoc 234:59–72, 2009; Sikorska et al., Adv Exp Med Biol 724:76–90, 2012). A more recently emerging prionoses is chronic wasting disease (CWD), which infects large numbers of cervids in North America, with the potential to infect other agriculturally important species and domestic animals, as well as humans (Rubenstein et al., Prion diagnosis. Manual of clinical and laboratory immunology, 2015; Saunders et al., Emerg Infect Dis 18:369–376, 2012; Gilch et al., Top Curr Chem 305:51–77, 2011; Daus and Beekes, Prion 6:17–22, 2012; Mathiason et al., J Virol 87:1947–1956, 2013). CWD is the most efficiently transmissible naturally occurring prion disease, including by aerosol transmission (Denkers et al., J Virol 87:1890–1892, 2013). In this chapter we review current knowledge regarding TSE and potential therapeutic approaches that are under development.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Reference List
Abrams JY, Maddox RA, Harvey AR, Schonberger LB, Belay ED (2011) Travel history, hunting, and venison consumption related to prion disease exposure, 2006-2007 FoodNet Population Survey. J Am Diet Assoc 111(6):858–863
Aguilar-Calvo P, Garcia C, Espinosa JC, Andreoletti O, Torres JM (2015) Prion and prion-like diseases in animals. Virus Res 207:82–93
Aguzzi A, Falsig J (2012) Prion propagation, toxicity and degradation. Nat Neurosci 15(7):936–939
Aguzzi A, O’Connor T (2010) Protein aggregation diseases: pathogenicity and therapeutic perspectives. Nat Rev Drug Discov 9(3):237–248
Aguzzi A, Sigurdson CJ (2004) Antiprion immunotherapy: to suppress or to stimulate? Nat Rev Immunol 4(9):725–736
Aguzzi A, Nuvolone M, Zhu C (2013) The immunobiology of prion diseases. Nat Rev Immunol 13(12):888–902
Alzualde A, Indakoetxea B, Ferrer I, Moreno F, Barandiaran M, Gorostidi A et al (2010) A novel PRNP Y218N mutation in Gerstmann-Straussler-Scheinker disease with neurofibrillary degeneration. J Neuropathol Exp Neurol 69(8):789–800
Angers RC, Kang HE, Napier D, Browning S, Seward T, Mathiason C et al (2010) Prion strain mutation determined by prion protein conformational compatibility and primary structure. Science 328(5982):1154–1158
Appleby BS, Appleby KK, Crain BJ, Onyike CU, Wallin MT, Rabins PV (2009) Characteristics of established and proposed sporadic Creutzfeldt-Jakob disease variants. Arch Neurol 66(2):208–215
Asante EA, Smidak M, Grimshaw A, Houghton R, Tomlinson A, Jeelani A et al (2015) A naturally occurring variant of the human prion protein completely prevents prion disease. Nature 522(7557):478–481
Aucouturier P, Kascsak RJ, Frangione B, Wisniewski T (1999) Biochemical and conformational variability of human prion strains in sporadic Creutzfeldt-Jakob disease. Neurosci Lett 274:33–36
Aucouturier P, Carp RI, Carnaud C, Wisniewski T (2000) Prion diseases and the immune system. Clin Immunol 96:79–85
Aucouturier P, Geissmann F, Damotte D, Saborio GP, Meeker HC, Kascsak R et al (2001) Infected dendritic cells are sufficient for prion transmission to the CNS in mouse scrapie. J Clin Invest 108:703–708
Baron T (2002) Identification of inter-species transmission of prions strains. J Neuropathol Exp Neurol 61(5):377–383
Barria MA, Balachandran A, Morita M, Kitamoto T, Barron R, Manson J et al (2014) Molecular barriers to zoonotic transmission of prions. Emerg Infect Dis 20(1):88–97
Bateman D, Hilton D, Love S, Zeidler M, Beck J, Collinge J (1995) Sporadic Creutzfeldt-Jakob disease in a 18-year old in the UK. Lancet 346:1155–1156
Beekes M, McBride PA (2007) The spread of prions through the body in naturally acquired transmissible spongiform encephalopathies. FEBS J 274(3):588–605
Beekes M, McBride PA, Baldauf E (1998) Cerebral targeting indicates vagal spread of infection in hamsters fed with scrapie. J Gen Virol 3:601–607
Berberidou C, Xanthopoulos K, Paspaltsis I, Lourbopoulos A, Polyzoidou E, Sklaviadis T et al (2013) Homogenous photocatalytic decontamination of prion infected stainless steel and titanium surfaces. Prion 7(6):488–489
Berman PH, Davidson GS, Becker LE (1988) Progressive neurological deterioration in a 14-year-old girl. Pediatr Neurosci 14(1):42–49
Bessen RA, Marsh RF (1994) Distinct PrP properties suggest the molecular basis of strain variation in transmissible mink encephalopathy. J Virol 68:7859–7868
Brandner S, Raeber A, Sailer A, Blättler T, Fischer M, Weissmann C et al (1996) Normal host prion protein (PrPc) is required for scrapie spread within the central nervous system. Proc Natl Acad Sci U S A 93(23):13148–13151
Brazier MW, Davies P, Player E, Marken F, Viles JH, Brown DR (2008) Manganese binding to the prion protein. J Biol Chem 283(19):12831–12839
Brazier MW, Volitakis I, Kvasnicka M, White AR, Underwood JR, Green JE et al (2010) Manganese chelation therapy extends survival in a mouse model of M1000 prion disease. J Neurochem 114(2):440–451
Britton TC, Al-Sarraj S, Shaw C, Campbell T, Collinge J (1995) Sporadic Creutzfeldt-Jakob disease in a 16-year old in the UK. Lancet 346:1155
Brown DR (2011) Prions and manganese: a maddening beast. Metallomics 3(3):229–238
Brown DR, Qin K, Herms JW, Madlung A, Manson J, Strome R et al (1997) The cellular prion protein binds copper in vivo. Nature 390:684–687
Brown P, Rau EH, Johnson BK, Bacote AE, Gibbs CJ Jr, Gajdusek DC (2000) New studies on the heat resistance of hamster-adapted scrapie agent: threshold survival after ashing at 600 degrees C suggests an inorganic template of replication. Proc Natl Acad Sci U S A 97(7):3418–3421
Brown P, Brandel JP, Preese M, Sato T (2006) Iatrogenic Creutzfeldt-Jakob disease: the waning of an era. Neurology 67(3):389–393
Brown P, Brandel JP, Sato T, Nakamura Y, MacKenzie J, Will RG et al (2012) Iatrogenic Creutzfeldt-Jakob disease, final assessment. Emerg Infect Dis 18(6):901–907
Buganza M, Ferrari S, Cecchini ME, Orrico D, Monaco S, Zanusso G (2009) The oldest old Creutzfeldt-Jakob disease case. J Neurol Neurosurg Psychiatry 80(10):1140–1142
Calzolai L, Lysek DA, Perez DR, Guntert P, Wuthrich K (2005) Prion protein NMR structures of chickens, turtles, and frogs. Proc Natl Acad Sci U S A 102(3):651–655
Capellari S, Strammiello R, Saverioni D, Kretzschmar H, Parchi P (2011) Genetic Creutzfeldt-Jakob disease and fatal familial insomnia: insights into phenotypic variability and disease pathogenesis. Acta Neuropathol 121(1):21–37
Carp RI (1982) Transmission of scrapie by oral route: effect of gingival scarification. Lancet 1(8264):170–171
Carp RI, Rubenstein R (1991) Diversity and significance of scrapie strains. Semin Virol 2:203–213
Caughey B, Raymond GJ, Bessen RA (1998) Strain-dependent differences in b-sheet conformations of abnormal prion protein. J Biol Chem 273:32230–32235
Chung E, Ji Y, Sun Y, Kascsak R, Kascsak RB, Mehta P et al (2010) Anti-PrPC monoclonal antibody infusion as a novel treatment for Ab oligomer cognitive deficits. BMC Neurosci 11:130
Clewley JP, Kelly CM, Andrews N, Vogliqi K, Mallinson G, Kaisar M et al (2009) Prevalence of disease related prion protein in anonymous tonsil specimens in Britain: cross sectional opportunistic survey. BMJ 338:b1442
Colby DW, Prusiner SB (2011) Prions. Cold Spring Harb Perspect Biol 3(1):a006833
Collie DA, Summers DM, Sellar RJ, Ironside JW, Cooper S, Zeidler M et al (2003) Diagnosing variant Creutzfeldt-Jakob disease with the pulvinar sign: MR imaging findings in 86 neuropathologically confirmed cases. AJNR Am J Neuroradiol 24(8):1560–1569
Collinge J (1997) Human prion diseases and bovine spongiform encephalopathy (BSE). Hum Mol Genet 6(10):1699–1705
Collinge J, Rossor M (1996) A new variant of prion disease. Lancet 347(9006):916–917
Collinge J, Whitfield J, McKintosh E, Beck J, Mead S, Thomas DJ et al (2006) Kuru in the 21st century—an acquired human prion disease with very long incubation periods. Lancet 367(9528):2068–2074
Collins S, Law MG, Fletcher A, Boyd A, Kaldor J, Masters CL (1999) Surgical treatment and risk of sporadic Creutzfeldt-Jakob disease: a case-control study. Lancet 353(9154):693–697
Collins SJ, Sanchez-Juan P, Masters CL, Klug GM, van Duijn C, Poleggi A et al (2006) Determinants of diagnostic investigation sensitivities across the clinical spectrum of sporadic Creutzfeldt-Jakob disease. Brain 129(Pt 9):2278–2287
Corato M, Cereda C, Cova E, Ferrarese C, Ceroni M (2006) Young-onset CJD: age and disease phenotype in variant and sporadic forms. Funct Neurol 21(4):211–215
D’Castro L, Wenborn A, Gros N, Joiner S, Cronier S, Collinge J et al (2010) Isolation of proteinase K-sensitive prions using pronase E and phosphotungstic acid. PLoS One 5(12):e15679
Daus ML, Beekes M (2012) Chronic wasting disease: fingerprinting the culprit in risk assessments. Prion 6(1):17–22
de Marco MF, Linehan J, Gill ON, Clewley JP, Brandner S (2010) Large-scale immunohistochemical examination for lymphoreticular prion protein in tonsil specimens collected in Britain. J Pathol 222(4):380–387
de Pedro-Cuesta J, Mahillo-Fernandez I, Rabano A, Calero M, Cruz M, Siden A et al (2011) Nosocomial transmission of sporadic Creutzfeldt-Jakob disease: results from a risk-based assessment of surgical interventions. J Neurol Neurosurg Psychiatry 82(2):204–212
Denkers ND, Seelig DM, Telling GC, Hoover EA (2010) Aerosol and nasal transmission of chronic wasting disease in cervidized mice. J Gen Virol 91(Pt 6):1651–1658
Denkers ND, Telling GC, Hoover EA (2011) Minor oral lesions facilitate transmission of chronic wasting disease. J Virol 85(3):1396–1399
Denkers ND, Hayes-Klug J, Anderson KR, Seelig DM, Haley NJ, Dahmes SJ et al (2013) Aerosol transmission of chronic wasting disease in white-tailed deer. J Virol 87(3):1890–1892
Diack AB, Head MW, McCutcheon S, Boyle A, Knight R, Ironside JW et al (2014) Variant CJD. 18 years of research and surveillance. Prion 8(4):286–295
Diaz-Espinoza R, Soto C (2012) High-resolution structure of infectious prion protein: the final frontier. Nat Struct Mol Biol 19(4):370–377
Donaldson DS, Kobayashi A, Ohno H, Yagita H, Williams IR, Mabbott NA (2012) M cell-depletion blocks oral prion disease pathogenesis. Mucosal Immunol 5(2):216–225
Donaldson DS, Else KJ, Mabbott NA (2015) The gut-associated lymphoid tissues in the small intestine, not the large intestine, play a major role in oral prion disease pathogenesis. J Virol 89(18):9532–9547
Duffy P, Wolf J, Collins G, DeVoe AG, Streeten B, Cowen D (1974) Possible person-to-person transmission of Creutzfeldt-Jakob disease. N Engl J Med 290(12):692–693
Edgeworth JA, Farmer M, Sicilia A, Tavares P, Beck J, Campbell T et al (2011) Detection of prion infection in variant Creutzfeldt-Jakob disease: a blood-based assay. Lancet 377(9764):487–493
Eklund CM, Kennedy RC, Hadlow WJ (1967) Pathogenesis of scrapie virus infected mice. J Infect Dis 117:15–22
Espinosa JC, Morales M, Castilla J, Rogers M, Torres JM (2007) Progression of prion infectivity in asymptomatic cattle after oral bovine spongiform encephalopathy challenge. J Gen Virol 88(Pt 4):1379–1383
Forloni G, Artuso V, Roiter I, Morbin M, Tagliavini F (2013) Therapy in prion diseases. Curr Top Med Chem 13(19):2465–2476
Fraser H, Dickinson AG (1970) Pathogenesis of scrapie in the mouse: the role of the spleen. Nature 226(5244):462–463
Fraser H, DiDario AG (1978) Studies of the lymphoreticular system in the pathogenesis of scrapie: the role of spleen and thymus. J Comp Pathol 88:563–573
Frosh A, Smith LC, Jackson CJ, Linehan JM, Brandner S, Wadsworth JD et al (2004) Analysis of 2000 consecutive UK tonsillectomy specimens for disease-related prion protein. Lancet 364(9441):1260–1262
Gabizon R, Telling G, Meiner Z, Halimi M, Kahana I, Prusiner SB (1996) Insoluble wild-type and protease-resistant mutant prion protein in brains of patients with inherited prion disease. Nat Med 2(1):59–64
Gajdusek DC, Zigas V (1957) Degenerative disease of the central nervous system in New Guinea: the epidemic occurrence of “kuru” in the native population. N Engl J Med 257:974–978
Gajdusek DC, Zigas V (1959) Clinical, pathological and epidemiological study of an acute progressive degenerative disease of the central nervous system among natives of the eastern highlands of New Guinea. Am J Med 26:442–469
Gajdusek DC, Gibbs CJ Jr, Alpers M (1966) Experimental transmission of a kuru-like syndrome to chimpanzees. Nature 209:794–796
Gambetti P, Dong Z, Yuan J, Xiao X, Zheng M, Alsheklee A et al (2008) A novel human disease with abnormal prion protein sensitive to protease. Ann Neurol 63:697–708
Gerstmann J, Sträussler E, Scheinker I (1936) Uber eine eigenartige hereditar-familiare erkrankung des zentral-nervensystems sugleich ein beitrag zur frage des vorzeitigen lokalen alterns. Z Neurol 154:736–762
Ghetti B, Tagliavini F, Giaccone G, Bugiani O, Frangione B, Farlow MR et al (1994) Familial Gerstmann-Straussler-Scheinker disease with neurofibrillary tangles. Mol Neurobiol 8(1):41–48
Gilch S, Chitoor N, Taguchi Y, Stuart M, Jewell JE, Schatzl HM (2011) Chronic wasting disease. Top Curr Chem 305:51–77
Gill ON, Spencer Y, Richard-Loendt A, Kelly C, Dabaghian R, Boyes L et al (2013) Prevalent abnormal prion protein in human appendixes after bovine spongiform encephalopathy epizootic: large scale survey. BMJ 347:f5675
Glatzel M, Heppner FL, Albers KM, Aguzzi A (2001) Sympathetic innervation of lymphoreticular organs is rate-limiting for prion neuroinvasion. Neuron 31:25–34
Glaysher BR, Mabbott NA (2007) Role of the draining lymph node in scrapie agent transmission from the skin. Immunol Lett 109(1):64–71
Goedert M (2015) Alzheimer’s and Parkinson’s diseases: the prion concept in relation to assembled Abeta, tau, and alpha-synuclein. Science 349(6248):1255555
Goldfarb LG, Petersen MB, Tabaton M, Brown P, LeBlanc AC, Montagna P et al (1992) Fatal familial insomnia and familial Creutzfeldt-Jacob disease: disease phenotype determined by a DNA polymorphism. Science 258:806–808
Goni F, Knudsen EL, Schreiber F, Scholtzova H, Pankiewicz J, Carp RI et al (2005) Mucosal vaccination delays or prevents prion infection via an oral route. Neuroscience 133:413–421
Goni F, Prelli F, Schreiber F, Scholtzova H, Chung E, Kascsak R et al (2008) High titers of mucosal and systemic anti-PrP antibodies abrogates oral prion infection in mucosal vaccinated mice. Neuroscience 153:679–686
Goni F, Herline K, Peyser D, Wong K, Ji Y, Sun Y et al (2013) Immunomodulation targeting both Ab and tau pathological conformers ameliorates Alzheimer’s disease pathology in TgSwDI and 3xTg mouse models. J Neuroinflammation 10(1):150
Goni F, Mathiason CK, Yim L, Wong K, Hayes-Klug J, Nalls A et al (2015) Mucosal immunization with an attenuated Salmonella vaccine partially protects white-tailed deer from chronic wasting disease. Vaccine 33:726–733
Gordon WS (1946) Advances in veterinary research. Vet Rec 58:518–525
Greenlee JJ, Greenlee MH (2015) The transmissible spongiform encephalopathies of livestock. ILAR J 56(1):7–25
Griffith JS (1967) Self-replication and scrapie. Nature 215:1043–1044
Hadlow WJ (1959) Scrapie and kuru. Lancet 11:289–290
Halfmann R, Jarosz DF, Jones SK, Chang A, Lancaster AK, Lindquist S (2012) Prions are a common mechanism for phenotypic inheritance in wild yeasts. Nature 482(7385):363–368
Halliday M, Mallucci GR (2014) Targeting the unfolded protein response in neurodegeneration: a new approach to therapy. Neuropharmacology 76 Pt A:169–174
Hamir AN, Kunkle RA, Cutlip RC, Miller JM, O’Rourke KI, Williams ES et al (2005) Experimental transmission of chronic wasting disease agent from mule deer to cattle by the intracerebral route. J Vet Diagn Invest 17(3):276–281
Hamir AN, Kunkle RA, Cutlip RC, Miller JM, Williams ES, Richt JA (2006) Transmission of chronic wasting disease of mule deer to Suffolk sheep following intracerebral inoculation. J Vet Diagn Invest 18(6):558–565
Hamir AN, Greenlee JJ, Nicholson EM, Kunkle RA, Richt JA, Miller JM et al (2011) Experimental transmission of chronic wasting disease (CWD) from elk and white-tailed deer to fallow deer by intracerebral route: final report. Can J Vet Res 75(2):152–156
Harman JL, Silva CJ (2009) Bovine spongiform encephalopathy. J Am Vet Med Assoc 234(1):59–72
Harris DA, Huber MT, Vankijken P, Shyng SL, Chait BT, Wang R (1993) Processing of a cellular prion protein: identification of N-terminal and C-terminal cleavage sites. Biochemistry 32:1009–1016
Haybaeck J, Heikenwalder M, Klevenz B, Schwarz P, Margalith I, Bridel C et al (2011) Aerosols transmit prions to immunocompetent and immunodeficient mice. PLoS Pathog 7(1):e1001257
Head MW (2013) Human prion diseases: molecular, cellular and population biology. Neuropathology 33(3):221–236
Head MW, Ironside JW, Ghetti B, Jeffrey M, Piccardo P, Will RG (2015) Prion disease. In: Love S, Budka H, Ironside JW, Perry A (eds) Greenfield’s neuropathology, 9th edn. CRC, London, pp 1016–1086
Heisey DM, Mickelsen NA, Schneider JR, Johnson CJ, Johnson CJ, Langenberg JA et al (2010) Chronic wasting disease (CWD) susceptibility of several North American rodents that are sympatric with cervid CWD epidemics. J Virol 84(1):210–215
Heppner FL, Christ AD, Klein MA, Prinz M, Fried M, Kraehenbuhl JP et al (2001) Transepithelial prion transport by M cells. Nat Med 7(9):976–977
Hill AF, Zeidler M, Ironside J, Collinge J (1997) Diagnosis of new variant Creutzfeldt-Jakob disease by tonsil biopsy. Lancet 349(99):100
Hilton DA, Sutak J, Smith ME, Penney M, Conyers L, Edwards P et al (2004a) Specificity of lymphoreticular accumulation of prion protein for variant Creutzfeldt-Jakob disease. J Clin Pathol 57(3):300–302
Hilton DA, Ghani AC, Conyers L, Edwards P, McCardle L, Ritchie D et al (2004b) Prevalence of lymphoreticular prion protein accumulation in UK tissue samples. J Pathol 203(3):733–739
Hoover E, Mathiason C, Henderson AS, Haley NJ, Seeling DM, Denkers ND et al (2013) Studies of chronic wasting disease transmission in cervid and non-cervid species. Prion 7(S):7
Hosszu LLP, Baxter NJ, Jackson GS, Power A, Clarke AR (1999) Structural mobility of the human prion protein probed by backbone hydrogen exchange. Nat Struct Biol 6:740–743
Houston F, Foster JD, Chong A, Hunter N, Bostock CJ (2000) Transmission of BSE by blood transfusion in sheep. Lancet 356:999–1000
Hsiao K, Baker HF, Crow TJ, Poulter M, Owen F, Terwilliger JD et al (1989) Linkage of a prion protein missense variant to Gerstmann-Straussler syndrome. Nature 338:342–345
Imran M, Mahmood S (2011) An overview of human prion diseases. Virol J 8:559
Ironside JW (2012) Variant Creutzfeldt-Jakob disease: an update. Folia Neuropathol 50(1):50–56
Iwasaki Y, Tatsumi S, Mimuro M, Mori K, Ito M, Kitamoto T et al (2014) Panencephalopathic-type sporadic Creutzfeldt-Jakob disease with circumscribed spongy foci. Clin Neuropathol 33(2):160–164
Jacob A (1921) Uber eigenaritge erkrankungen des zentral-nervensystems mit bemerkenswertem anatomischen befunde (spastische pseudosklerose-encephalomyelopathie mit disseminierten degenerationsherden). Z Gesamte Neurol Psychiatre 64:147–228
James TL, Liu H, Ulyanov NB, Farr-Jones S, Zhang H, Donne DG et al (1997) Solution structure of a 142-residue recombinant prion protein corresponding to the infectious fragment of the scrapie isoform. Proc Natl Acad Sci U S A 94(19):10086–10091
Jansen C, Head MW, Rozemuller AJ, Ironside JW (2009) Panencephalopathic Creutzfeldt-Jakob disease in the Netherlands and the UK: clinical and pathological characteristics of nine patients. Neuropathol Appl Neurobiol 35(3):272–282
Jucker M, Walker LC (2011) Pathogenic protein seeding in Alzheimer disease and other neurodegenerative disorders. Ann Neurol 70(4):532–540
Kascsak RJ, Rubenstein R, Merz PA, Carp RI, Robakis NK, Wisniewski HM et al (1986) Immunological comparison of scrapie-associated fibrils isolated from animals infected with four different scrapie strains. J Virol 59(3):676–683
Kaski D, Mead S, Hyare H, Cooper S, Jampana R, Overell J et al (2009) Variant CJD in an individual heterozygous for PRNP codon 129. Lancet 374(9707):2128
Kim MO, Geschwind MD (2015) Clinical update of Jakob-Creutzfeldt disease. Curr Opin Neurol 28(3):302–310
Kim C, Haldiman T, Cohen Y, Chen W, Blevins J, Sy MS et al (2011) Protease-sensitive conformers in broad spectrum of distinct PrPSc structures in sporadic Creutzfeldt-Jakob disease are indicator of progression rate. PLoS Pathog 7(9):e1002242
Kim C, Haldiman T, Surewicz K, Cohen Y, Chen W, Blevins J et al (2012) Small protease sensitive oligomers of PrPSc in distinct human prions determine conversion rate of PrP(C). PLoS Pathog 8(8):e1002835
Kimberlin RH, Walker CA (1978) Evidence that the transmission of one source of scrapie agent to hamster involve separation of one source of scrapie agent to hamsters involve separation of agent strains from a mixture. J Gen Virol 39:487–496
Kimberlin RH, Walker CA (1979) Pathogenesis of mouse scrapie: dynamics of agent replication in spleen, spinal cord and brain after injection by different routes. J Comp Pathol 89:551–562
Kimberlin RH, Walker CA (1989a) Pathogenesis of scrapie in mice after intragastric infection. Virus Res 12(3):213–220
Kimberlin RH, Walker CA (1989b) The role of the spleen in the neuroinvasion of scrapie in mice. Virus Res 12:201–212
Knaus KJ, Morillas M, Swietnicki W, Malone M, Surewicz WK, Yee VC (2002) Crystal structure of the human prion protein reveals a mechanism for oligomerization. Nat Struct Biol 8:770–774
Kobayashi A, Teruya K, Matsuura Y, Shirai T, Nakamura Y, Yamada M et al (2015) The influence of PRNP polymorphisms on human prion disease susceptibility: an update. Acta Neuropathol 130(2):159–170
Kong Q, Huang S, Zou W, Vanegas D, Wang M, Wu D et al (2005) Chronic wasting disease of elk: transmissibility to humans examined by transgenic mouse models. J Neurosci 25(35):7944–7949
Kostylev MA, Kaufman AC, Nygaard HB, Patel P, Haas LT, Gunther EC et al (2015) Prion-protein-interacting amyloid-beta oligomers of high molecular weight are tightly correlated with memory impairment in multiple Alzheimer mouse models. J Biol Chem 290(28):17415–17438
Kovacs GG, Puopolo M, Ladogana A, Pocchiari M, Budka H, van Duijn C et al (2005) Genetic prion disease: the EUROCJD experience. Hum Genet 118(2):166–174
Kretzschmar H, Tatzelt J (2013) Prion disease: a tale of folds and strains. Brain Pathol 23(3):321–332
Krumm CE, Conner MM, Hobbs NT, Hunter DO, Miller MW (2010) Mountain lions prey selectively on prion-infected mule deer. Biol Lett 6(2):209–211
Kurt TD, Seelig DM, Schneider JR, Johnson CJ, Telling GC, Heisey DM et al (2011) Alteration of the chronic wasting disease species barrier by in vitro prion amplification. J Virol 85(17):8528–8537
Kurt TD, Jiang L, Fernandez-Borges N, Bett C, Liu J, Yang T et al (2015) Human prion protein sequence elements impede cross-species chronic wasting disease transmission. J Clin Invest 125(4):1485–1496
LaCasse RA, Striebel JF, Favara C, Kercher L, Chesebro B (2008) Role of Erk1/2 activation in prion disease pathogenesis: absence of CCR1 leads to increased Erk1/2 activation and accelerated disease progression. J Neuroimmunol 196(1–2):16–26
Liberski PP, Sikorska B (2012) Human prion diseases: from kuru to variant Creutzfeldt-Jakob disease. Subcell Biochem 65:457–496
Liberski PP, Surewicz WK (2013) Molecular genetics of Gerstmann-Straussler-Scheinker disease and Creutzfeldt-Jakob disease. Genetics 2:117
Mabbott NA, MacPherson GG (2006) Prions and their lethal journey to the brain. Nat Rev Microbiol 4(3):201–211
Mahillo-Fernandez I, de Pedro-Cuesta J, Bleda MJ, Cruz M, Molbak K, Laursen H et al (2008) Surgery and risk of sporadic Creutzfeldt-Jakob disease in Denmark and Sweden: registry-based case-control studies. Neuroepidemiology 31(4):229–240
Marciniuk K, Taschuk R, Napper S (2013) Evidence for prion-like mechanisms in several neurodegenerative diseases: potential implications for immunotherapy. Clin Dev Immunol 2013:473706
Marsh RF, Kincaid AE, Bessen RA, Bartz JC (2005) Interspecies transmission of chronic wasting disease prions to squirrel monkeys (Saimiri sciureus). J Virol 79(21):13794–13796
Mastrianni JA (2010) The genetics of prion diseases. Genet Med 12(4):187–195
Mastrianni JA, Nixon R, Layzer R, Telling GC, Han D, DeArmond SJ et al (1999) Prion protein conformation in a patient with sporadic fatal insomnia. N Engl J Med 340(21):1630–1638
Mathiason CK, Powers JG, Dahmes SJ, Osborn DA, Miller KV, Warren RJ et al (2006) Infectious prions in the saliva and blood of deer with chronic wasting disease. Science 314(5796):133–136
Mathiason CK, Nalls AV, Seelig DM, Kraft SL, Carnes K, Anderson KR et al (2013) Susceptibility of domestic cats to chronic wasting disease. J Virol 87(4):1947–1956
Mead S, Stumpf MP, Whitfield J, Beck JA, Poulter M, Campbell T et al (2003) Balancing selection at the prion protein gene consistent with prehistoric kurulike epidemics. Science 300(5619):640–643
Mead S, Whitfield J, Poulter M, Shah P, Uphill J, Beck J et al (2008) Genetic susceptibility, evolution and the kuru epidemic. Philos Trans R Soc Lond B Biol Sci 363(1510):3741–3746
Mead S, Whitfield J, Poulter M, Shah P, Uphill J, Campbell T et al (2009) A novel protective prion protein variant that colocalizes with kuru exposure. N Engl J Med 361(21):2056–2065
Mead S, Gandhi S, Beck J, Caine D, Gallujipali D, Carswell C et al (2013) A novel prion disease associated with diarrhea and autonomic neuropathy. N Engl J Med 369(20):1904–1914
Medori R, Trischler HJ, LeBlanc A, Villare F, Manetto V, Chen HY et al (1992) Fatal familial insomnia, a prion disease with a mutation at codon 178 of the prion protein gene. N Engl J Med 326:444–449
Meissner B, Kallenberg K, Sanchez-Juan P, Collie D, Summers DM, Almonti S et al (2009) MRI lesion profiles in sporadic Creutzfeldt-Jakob disease. Neurology 72(23):1994–2001
Mitchell GB, Sigurdson CJ, O’Rourke KI, Algire J, Harrington NP, Walther I et al (2012) Experimental oral transmission of chronic wasting disease to reindeer (Rangifer tarandus tarandus). PLoS One 7(6):e39055
Mitrova E, Belay G (2002) Creutzfeldt-Jakob disease with E200K mutation in Slovakia: characterization and development. Acta Virol 46(1):31–39
Miura T, Hori-i A, Takeuchi H (1996) Metal-dependent alpha-helix formation promoted by the glycine-rich octapeptide region of prion protein. FEBS Lett 396(2–3):248–252
Mizutani T, Okumura A, Oda M, Shiraki H (1981) Panencephalopathic type of Creutzfeldt-Jakob disease: primary involvement of the cerebral white matter. J Neurol Neurosurg Psychiatry 44(2):103–115
Mohan J, Brown KL, Farquhar CF, Bruce ME, Mabbott NA (2004) Scrapie transmission following exposure through the skin is dependent on follicular dendritic cells in lymphoid tissues. J Dermatol Sci 35(2):101–111
Montagna P, Gambetti P, Cortelli P, Lugaresi E (2003) Familial and sporadic fatal insomnia. Lancet Neurol 2(3):167–176
Morel E, Andrieu T, Casagrande F, Gauczynski S, Weiss S, Grassi J et al (2005) Bovine prion is endocytosed by human enterocytes via the 37 kDa/67 kDa laminin receptor. Am J Pathol 167(4):1033–1042
Moreno JA, Halliday M, Molloy C, Radford H, Verity N, Axten JM et al (2013) Oral treatment targeting the unfolded protein response prevents neurodegeneration and clinical disease in prion-infected mice. Sci Transl Med 5(206):206ra138
Mouillet-Richard S, Ermonval M, Chebassier C, Laplanche JL, Lehmann S, Launay JM et al (2000) Signal transduction through prion protein. Science 289(5486):1925–1928
Natale G, Ferrucci M, Lazzeri G, Paparelli A, Fornai F (2011) Transmission of prions within the gut and towards the central nervous system. Prion 5(3):142–149
Newby GA, Lindquist S (2013) Blessings in disguise: biological benefits of prion-like mechanisms. Trends Cell Biol 23(6):251–259
Nichols TA, Spraker TR, Rigg TD, Meyerett-Reid C, Hoover C, Michel B et al (2013) Intranasal inoculation of white-tailed deer (Odocoileus virginianus) with lyophilized chronic wasting disease prion particulate complexed to montmorillonite clay. PLoS One 8(5):e62455
Nygaard HB, Wagner AF, Bowen GS, Good SP, MacAvoy MG, Strittmatter KA et al (2015) A phase Ib multiple ascending dose study of the safety, tolerability, and central nervous system availability of AZD0530 (saracatinib) in Alzheimer’s disease. Alzheimers Res Ther 7(1):35
Pan KM, Baldwin M, Njuyen J, Gassett M, Serban A, Groth D et al (1993) Conversion of alpha-helices into b-sheets features in the formation of scrapie prion proteins. Proc Natl Acad Sci U S A 90:10962–10966
Parchi P, Saverioni D (2012) Molecular pathology, classification, and diagnosis of sporadic human prion disease variants. Folia Neuropathol 50(1):20–45
Parchi P, Castellani R, Capellari S, Ghetti B, Young K, Chen SG et al (1996) Molecular basis of phenotypic variability in sporadic Creutzfeldt-Jacob disease. Ann Neurol 39:767–778
Parchi P, Giese A, Capellari S, Brown P, Schulz-Schaeffer W, Windl O et al (1999) Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol 46(2):224–233
Parchi P, Strammiello R, Notari S, Giese A, Langeveld JP, Ladogana A et al (2009) Incidence and spectrum of sporadic Creutzfeldt-Jakob disease variants with mixed phenotype and co-occurrence of PrPSc types: an updated classification. Acta Neuropathol 118(5):659–671
Parchi P, de Boni L, Saverioni D, Cohen ML, Ferrer I, Gambetti P et al (2012) Consensus classification of human prion disease histotypes allows reliable identification of molecular subtypes: an inter-rater study among surveillance centres in Europe and USA. Acta Neuropathol 124(4):517–529
Parker SE, Gujrati M, Pula JH, Zallek SN, Kattah JC (2014) The Heidenhain variant of Creutzfeldt-Jakob disease—a case series. J Neuroophthalmol 34(1):4–9
Pastrana MA, Sajnani G, Onisko B, Castilla J, Morales R, Soto C et al (2006) Isolation and characterization of a proteinase K-sensitive PrPSc fraction. Biochemistry 45(51):15710–15717
Pattison IH, Millson GC (1960) Further observations on the experimental production of scrapie in goats and sheep. J Comp Pathol 70:182–193
Peden AH, Head MW, Ritchie DL, Bell JE, Ironside JW (2004) Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient. Lancet 364(9433):527–529
Peden AH, McGuire LI, Appleford NE, Mallinson G, Wilham JM, Orru CD et al (2012) Sensitive and specific detection of sporadic Creutzfeldt-Jakob disease brain prion protein using real-time quaking induced conversion. J Gen Virol 93(Pt 2):438–449
Perez DR, Damberger FF, Wuthrich K (2010) Horse prion protein NMR structure and comparisons with related variants of the mouse prion protein. J Mol Biol 400(2):121–128
Pocchiari M, Puopolo M, Croes EA, Budka H, Gelpi E, Collins S et al (2004) Predictors of survival in sporadic Creutzfeldt-Jakob disease and other human transmissible spongiform encephalopathies. Brain 127(Pt 10):2348–2359
Pradines E, Loubet D, Schneider B, Launay JM, Kellermann O, Mouillet-Richard S (2008) CREB-dependent gene regulation by prion protein: impact on MMP-9 and beta-dystroglycan. Cell Signal 20(11):2050–2058
Prinz M, Huber G, Macpherson AJ, Heppner FL, Glatzel M, Eugster HP et al (2003) Oral prion infection requires normal numbers of Peyer’s patches but not of enteric lymphocytes. Am J Pathol 162(4):1103–1111
Prusiner SB (1982) Novel proteinaceous infectious particles cause scrapie. Science 216:136–144
Prusiner SB (2012) Cell biology. A unifying role for prions in neurodegenerative diseases. Science 336(6088):1511–1513
Prusiner SB (2013) Biology and genetics of prions causing neurodegeneration. Annu Rev Genet 47:601–623
Prusiner SB, Hsiao KK (1994) Human prion diseases. Ann Neurol 35(4):385–395
Prusiner SB, Scott MR, DeArmond SJ, Cohen FE (1998) Prion protein biology. Cell 93:337–348
Puopolo M, Ladogana A, Vetrugno V, Pocchiari M (2011) Transmission of sporadic Creutzfeldt-Jakob disease by blood transfusion: risk factor or possible biases. Transfusion 51(7):1556–1566
Puoti G, Bizzi A, Forloni G, Safar JG, Tagliavini F, Gambetti P (2012) Sporadic human prion diseases: molecular insights and diagnosis. Lancet Neurol 11(7):618–628
Race B, Meade-White KD, Miller MW, Barbian KD, Rubenstein R, LaFauci G et al (2009) Susceptibilities of nonhuman primates to chronic wasting disease. Emerg Infect Dis 15(9):1366–1376
Rachidi W, Vilette D, Guiraud P, Arlotto M, Riondel J, Laude H et al (2003) Expression of prion protein increases cellular copper binding and antioxidant enzyme activities but not copper delivery. J Biol Chem 278(11):9064–9072
Rasool S, Martinez-Coria H, Wu JW, LaFerla F, Glabe CG (2013) Systemic vaccination with anti-oligomeric monoclonal antibodies improves cognitive function by reducing Abeta deposition and tau pathology in 3xTg-AD mice. J Neurochem 126(4):473–482
Raveendra BL, Siemer AB, Puthanveettil SV, Hendrickson WA, Kandel ER, McDermott AE (2013) Characterization of prion-like conformational changes of the neuronal isoform of Aplysia CPEB. Nat Struct Mol Biol 20(4):495–501
Raymond CR, Aucouturier P, Mabbott NA (2007) In vivo depletion of CD11c + cells impairs scrapie agent neuroinvasion from the intestine. J Immunol 179(11):7758–7766
Rieger R, Edenhofer F, Lasmezas CI, Weiss S (1997) The human 37-kDa laminin receptor precursor interacts with the prion protein in eukaryotic cells. Nat Med 3(12):1383–1388
Riek R, Hornemann S, Wider G, Billeter M, Glockshuber R, Wüthrich K (1996) NMR structure of the mouse prion protein domain PrP(121-231). Nature 382(6587):180–182
Riek R, Hornemann S, Wider G, Glockshuber R, Wüthrich K (1997) NMR characterization of the full-length recombinant murine prion protein, mPrP(23-231). FEBS Lett 413(2):282–288
Robinson SJ, Samuel MD, O’Rourke KI, Johnson CJ (2012) The role of genetics in chronic wasting disease of North American cervids. Prion 6(2):153–162
Roettger Y, Du Y, Bacher M, Zerr I, Dodel R, Bach JP (2013) Immunotherapy in prion disease. Nat Rev Neurol 9(2):98–105
Rubenstein R, Peterson R, Wisniewski T (2016) Prion diagnosis. Manual of clinical and laboratory immunology (2016)
Safar JG, Lessard P, Tamguney G, Freyman Y, Deering C, Letessier F et al (2008) Transmission and detection of prions in feces. J Infect Dis 198(1):81–89
Sajnani G, Silva CJ, Ramos A, Pastrana MA, Onisko BC, Erickson ML et al (2012) PK-sensitive PrP is infectious and shares basic structural features with PK-resistant PrP. PLoS Pathog 8(3):e1002547
Sandberg M, Al-Doujaily H, Sigurdson C, Glatzel M, O’Malley C, Powell C et al (2010) Chronic wasting disease prions are not transmissible to transgenic mice over-expressing human prion protein. J Gen Virol 91(Pt 10):2651–2657
Saunders SE, Bartelt-Hunt SL, Bartz JC (2012) Occurrence, transmission, and zoonotic potential of chronic wasting disease. Emerg Infect Dis 18(3):369–376
Schutt CR, Bartz JC (2008) Prion interference with multiple prion isolates. Prion 2(2):61–63
Shikiya RA, Ayers JI, Schutt CR, Kincaid AE, Bartz JC (2010) Coinfecting prion strains compete for a limiting cellular resource. J Virol 84(11):5706–5714
Shmakov AN, Ghosh S (2001) Prion proteins and the gut: une liaison dangereuse? Gut 48(4):443–447
Si K, Choi YB, White-Grindley E, Majumdar A, Kandel ER (2010) Aplysia CPEB can form prion-like multimers in sensory neurons that contribute to long-term facilitation. Cell 140(3):421–435
Sigurdson CJ (2008) A prion disease of cervids: chronic wasting disease. Vet Res 39(4):41
Sigurdson CJ, Williams ES, Miller MW, Spraker TR, O’Rourke KI, Hoover EA (1999) Oral transmission and early lymphoid tropism of chronic wasting disease PrPres in mule deer fawns (Odocoileus hemionus). J Gen Virol 80(Pt 10):2757–2764
Sigurdsson EM, Brown DR, Alim MA, Scholtzova H, Carp RI, Meeker HC et al (2003) Copper chelation delays the onset of prion disease. J Biol Chem 278:46199–46202
Sikorska B, Knight R, Ironside JW, Liberski PP (2012) Creutzfeldt-Jakob disease. Adv Exp Med Biol 724:76–90
Sim VL (2012) Prion disease: chemotherapeutic strategies. Infect Disord Drug Targets 12(2):144–160
Singh J, Udgaonkar JB (2015) Molecular mechanism of the misfolding and oligomerization of the prion protein: current understanding and its implications. Biochemistry 54(29):4431–4442
Singh A, Haldar S, Horback K, Tom C, Zhou L, Meyerson H et al (2013) Prion protein regulates iron transport by functioning as a ferrireductase. J Alzheimers Dis 35(3):541–552
Takada LT, Geschwind MD (2013) Prion diseases. Semin Neurol 33(4):348–356
Tamguney G, Giles K, Bouzamondo-Bernstein E, Bosque PJ, Miller MW, Safar J et al (2006) Transmission of elk and deer prions to transgenic mice. J Virol 80(18):9104–9114
Thackray AM, Knight R, Haswell SJ, Bujdoso R, Brown DR (2002) Metal imbalance and compromised antioxidant function are early changes in prion disease. Biochem J 362:253–258
Trevitt CR, Collinge J (2006) A systematic review of prion therapeutics in experimental models. Brain 129(Pt 9):2241–2265
Tzaban S, Friedlander G, Schonberger O, Horonchik L, Yedidia Y, Shaked G et al (2002) Protease-sensitive scrapie prion protein in aggregates of heterogeneous sizes. Biochemistry 41(42):12868–12875
Um JW, Nygaard HB, Heiss JK, Kostylev MA, Stagi M, Vortmeyer A et al (2012) Alzheimer amyloid-b oligomer bound to post-synaptic prion protein activates Fyn to impair neurons. Nat Neurosci 15(9):1227–1235
Um JW, Kaufman AC, Kostylev MA, Heiss JK, Stagi M, Takahashi H et al (2013) Metabotropic glutamate receptor 5 mediates signaling from Alzheimer Ab oligomer bound to prion protein. Neuron 79(5):887–902
Weissmann C (1996) Molecular biology of transmissible spongiform encephalopathies. FEBS Lett 389(1):3–11
Wickner RB, Edskes HK, Kryndushkin D, McGlinchey R, Bateman D, Kelly A (2011) Prion diseases of yeast: amyloid structure and biology. Semin Cell Dev Biol 22(5):469–475
Wickner RB, Edskes HK, Bateman DA, Kelly AC, Gorkovskiy A, Dayani Y et al (2013) Amyloids and yeast prion biology. Biochemistry 52(9):1514–1527
Wickner RB, Shewmaker FP, Bateman DA, Edskes HK, Gorkovskiy A, Dayani Y et al (2015) Yeast prions: structure, biology, and prion-handling systems. Microbiol Mol Biol Rev 79(1):1–17
Williams ES (2005) Chronic wasting disease. Vet Pathol 42(5):530–549
Williams ES, Young S (1980) Chronic wasting disease of captive mule deer: a spongiform encephalopathy. J Wildl Dis 16(1):89–98
Williams ES, Young S (1982) Spongiform encephalopathy of Rocky Mountain elk. J Wildl Dis 18(4):465–471
Windl O, Dempster M, Estibeiro P, Lathe R (1995) A candidate marsupial PrP gene reveals two domains conserved in mammalian PrP proteins. Gene 159:181–186
Windl O, Dempster M, Estibeiro JP, Lathe R, de Silva R, Esmonde T et al (1996) Genetic basis of Creutzfeldt-Jakob disease in the United Kingdom: a systematic analysis of predisposing mutations and allelic variation in the PRNP gene. Hum Genet 98(3):259–264
Windl O, Giese A, Schulz-Schaeffer W, Zerr I, Skworc K, Arendt S et al (1999) Molecular genetics of human prion diseases in Germany. Hum Genet 105(3):244–252
Wisniewski T, Goni F (2012) Could immunomodulation be used to prevent prion diseases? Expert Rev Anti Infect Ther 10(3):307–317
Wisniewski T, Goni F (2014) Immunotherapy for Alzheimer’s disease. Biochem Pharmacol 88:499–507
Wisniewski T, Goni F (2015) Immunotherapeutic approaches for Alzheimer’s disease. Neuron 85:1162–1176
Zaman SM, Hill FG, Palmer B, Millar CM, Bone A, Molesworth AM et al (2011) The risk of variant Creutzfeldt-Jakob disease among UK patients with bleeding disorders, known to have received potentially contaminated plasma products. Haemophilia 17(6):931–937
Zeidler M, Sellar RJ, Collie DA (2000) The pulvinar sign on magnetic resonance imaging in variant Creutzfeldt-Jakob disease. Lancet 355:1412–1418
Zou WQ, Puoti G, Xiao X, Yuan J, Qing L, Cali I et al (2010) Variably protease-sensitive prionopathy: a new sporadic disease of the prion protein. Ann Neurol 68(2):162–172
Zou WQ, Gambetti P, Xiao X, Yuan J, Langeveld J, Pirisinu L (2013) Prions in variably protease-sensitive prionopathy: an update. Pathogens 2(3):457–471
Acknowledgments
This work was supported by NIH grants: NS073502 and AG20245, as well as the Seix Dow Foundation.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Wisniewski, T., Goñi, F. (2016). Transmissible Spongiform Encephalopathies. In: Reiss, C. (eds) Neurotropic Viral Infections. Springer, Cham. https://doi.org/10.1007/978-3-319-33189-8_7
Download citation
DOI: https://doi.org/10.1007/978-3-319-33189-8_7
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-33188-1
Online ISBN: 978-3-319-33189-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)